(Press-News.org) New research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241506 found an increase in asthma-related emergency department (ED) visits across Ontario following heavy smoke in early June 2023.
Canada experienced the most destructive wildfire season to date in 2023, with difficult-to-control fires across the country, including 29 mega-fires. One fire in Quebec, the province’s largest-ever wildfire, extended 1.2 million acres. Smoke from fires blanketed Canada and the United States, causing substantial damage, loss, and displacement.
“The unprecedented wildfires of 2023 are a wake-up call that wildfires — a persistent feature of Canada’s landscape — are becoming more intense and prolonged in a changing climate, affecting millions of people,” writes Dr. Hong Chen, a scientist with Health Canada, ICES, and Public Health Ontario, with coauthors.
In early June, Ontario had some of the world’s worst air quality from wildfires in the neighbouring province of Quebec. To understand the impact on health, researchers conducted a study, analyzing ED visits throughout the period from 8 weeks before a major wildfire event in early June until July 31, 2023, 4 weeks after a second fire that resulted in smoke. The analysis included data from 30 public health units in Ontario, representing 95% of the population. They found daily increases of 11% to 24% in asthma-related emergency department visits over the first episode, continuing up to 6 days after it ended. However, the second period of heavy smoke did not result in an increase in asthma-related ED visits.
“[P]ossible explanations [of the lack of effect during the second episode] include extended protective effects of preventive medications prescribed during the first episode, increased supply and use of medications (e.g., caregiver administration of maintenance medication to children), or improved behavioural adaptations to minimize exposure in keeping with air-quality advisories, such as staying indoors and using air filters.”
As wildfires are a major environmental risk factor around the world and are increasing in frequency and severity, the researchers note that more research is needed to better understand their impact on health and how to mitigate health effects.
“The biggest impact of wildfire smoke is on acute respiratory morbidity, where its effects are consistently greater than those of air pollution from other sources,” writes Dr. Sarah Henderson from the BC Centre for Disease Control, in a related commentary https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250510. “Less clear associations have been shown for a much wider range of acute health outcomes, including cognition, diabetic control, and mental health, among many others.”
Dr. Henderson highlights that wildfire smoke frequently affects air quality in the west and calls for Canada to develop a consistent approach to reducing indoor and outdoor exposures.
END
ED visits for asthma spiked during 2023 Canadian wildfires
2025-05-05
ELSE PRESS RELEASES FROM THIS DATE:
Making virtual reality more accessible
2025-05-05
A team of researchers from the University of Waterloo have created a method that makes virtual reality (VR) more accessible to people with mobility limitations.
VR games like Beat Saber and Space Pirate Trainer usually require large and dramatic movements, such as raising one’s arms above the head or quickly side-stepping, which can be difficult or impossible for people who use wheelchairs or have limited mobility. To decrease these barriers, the researchers created MotionBlocks, a tool that lets users customize ...
AAAS CEO testifies in Senate hearing on biomedical innovation
2025-05-05
AAAS CEO, Sudip S. Parikh, testified as a bipartisan witness before the Senate Appropriations Committee Wednesday, April 30, for a hearing discussing biomedical research in America. Dr. Parikh was joined by three other executives and one patient advocate to express the importance of American support and funding for biomedical research. In Dr. Parikh’s written testimony, he cites the biomedical research ecosystem developed in the United States as the “greatest engine for discovery in the service of health that the world has ever known,” while ...
Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk patients
2025-05-04
Vienna, Austria – Endometrial cancer is the most common gynecological cancer in high-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.* For women with high-intermediate risk disease, adjuvant radiotherapy — particularly vaginal brachytherapy (a form of internal radiotherapy delivered directly to the vaginal area) — is commonly used after surgery to reduce the risk of recurrence. However, patients don’t need it equally, and some may receive more treatment than necessary, exposing ...
New radiotherapy technique aims to protect the heart during lung cancer treatment
2025-05-04
Learning from Every Patient: New Radiotherapy Technique Aims to Protect the Heart During Lung Cancer Treatment
Vienna, Austria – A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. Traditional clinical trials are often lengthy and are not representative of real-world patient populations due to complex consent processes and strict eligibility criteria. In contrast, RAPID-RT offers a more inclusive, real-world alternative. Researchers at The Christie NHS Foundation Trust in Manchester, UK, have applied this method in lung cancer patients to assess ...
Five major advances in anal and rectal cancer treatment with radiotherapy
2025-05-03
Vienna, Austria – Rectal cancer is a type of bowel cancer that develops in the last several centimetres of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 people diagnosed annually*. Treatment traditionally involves surgery to remove the tumour—a major operation that can permanently affect sexual function, continence, and quality of life.
While radiotherapy and chemotherapy are already used to shrink tumours before surgery, there is growing momentum behind treatment strategies that avoid surgery ...
SCAI announces Srihari S. Naidu, MD, MSCAI, President for 2025–26
2025-05-03
WASHINGTON— The Society for Cardiovascular Angiography & Interventions (SCAI) has announced its new leadership for 2025–26, with Srihari S. Naidu, MD, MSCAI, assuming the role of President during SCAI Scientific Sessions 2025, held May 1–3 in Washington, DC.
Dr. Naidu is Professor of Medicine at New York Medical College and System Director of the Cardiac Catheterization Laboratories and Hypertrophic Cardiomyopathy (HCM) National Center of Excellence at Westchester Medical Center in Valhalla, NY. A leading interventional cardiologist, he is internationally recognized for his work in hypertrophic cardiomyopathy and ...
Turning point in stomach cancer: Early-stage diagnoses now more common
2025-05-03
SAN DIEGO, CA. (MAY 3, 2025) Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages — a shift that marks major progress in detecting one of the deadliest forms of cancer, according to a study to be presented today at Digestive Disease Week® (DDW) 2025.
“These trends suggest that advancements in endoscopic imaging, along with more widespread use of upper endoscopy, may be helping doctors find stomach cancer earlier,” said Mohamed Tausif Siddiqui, MD, the study’s ...
Anal cancer rates rising most among older, white and Hispanic women
2025-05-03
SAN DIEGO, CA. (MAY 3, 2025) — Anal cancer has been steadily increasing in the United States, with the biggest jumps among older women, especially white and Hispanic women — a shift that challenges assumptions about high-risk groups and who should be screened, according to a study to be presented today at Digestive Disease Week® (DDW) 2025.
“Rates of anal cancer are rising fastest among white and Hispanic women over 65 — groups not traditionally considered high risk,” said lead author Ashley Robinson, MD, a second-year internal medicine resident at Advocate Lutheran General Hospital. “While the exact reasons behind ...
Scientists fight Alzheimer’s by helping glial cells process glucose
2025-05-03
Tokyo, Japan – Researchers from Tokyo Metropolitan University have discovered that impaired glucose metabolism in glial cells, a type of cell in our nervous system, plays a key role in the degeneration caused by Alzheimer’s disease. Using fruit fly retinas, they showed that promoting glucose metabolism in glial cells with tau protein build-up, like in Alzheimer’s patients, helps relieve inflammation and photoreceptor degeneration. Their findings present an exciting new therapeutic target for treating neurodegenerative conditions.
Alzheimer’s ...
Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial
2025-05-02
Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up in Phase III Trial
Vienna, Austria — Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each year [1]. For many patients, radiotherapy is a standard treatment option that offers outcomes comparable to surgery, particularly for localised disease [2]. As an outpatient procedure, it allows men to maintain much of their daily ...